Gene symbol: Adra2a

Also known as: RG20; CA2-47; RATRG20

Organism: Rattus norvegicus

Summary: Enables alpha2-adrenergic receptor activity. Involved in several processes, including glucose homeostasis; negative regulation of secretion by cell; and negative regulation of uterine smooth muscle contraction. Located in several cellular components, including axon terminus; neuronal cell body; and plasma membrane. Is active in GABA-ergic synapse and glutamatergic synapse. Is integral component of postsynaptic density membrane and integral component of presynaptic active zone membrane. Used to study anxiety disorder and mental depression. Biomarker of hypertension and type 2 diabetes mellitus. Human ortholog(s) of this gene implicated in attention deficit hyperactivity disorder and type 2 diabetes mellitus. Orthologous to human ADRA2A (adrenoceptor alpha 2A). [provided by Alliance of Genome Resources, Apr 2022]

NCBI gene ID: 25083 EnsemblRapid:ENSRNOG00000047545 AllianceGenome:RGD:2056


GO Annotation


Category Term ID Term description
Process GO:0000003 Reproduction
Process GO:0001505 Regulation of neurotransmitter levels
Process GO:0001775 Cell activation
Process GO:0001817 Regulation of cytokine production
Process GO:0001819 Positive regulation of cytokine production
Process GO:0001932 Regulation of protein phosphorylation
Process GO:0001934 Positive regulation of protein phosphorylation
Process GO:0002526 Acute inflammatory response
Process GO:0002791 Regulation of peptide secretion
Process GO:0002792 Negative regulation of peptide secretion
Process GO:0003008 System process
Process GO:0003013 Circulatory system process
Process GO:0003018 Vascular process in circulatory system
Process GO:0006139 Nucleobase-containing compound metabolic process
Process GO:0006259 DNA metabolic process
Process GO:0006260 DNA replication
Process GO:0006725 Cellular aromatic compound metabolic process
Process GO:0006807 Nitrogen compound metabolic process
Process GO:0006937 Regulation of muscle contraction
Process GO:0006940 Regulation of smooth muscle contraction
Process GO:0006950 Response to stress
Process GO:0006952 Defense response
Process GO:0006954 Inflammatory response
Process GO:0007154 Cell communication
Process GO:0007165 Signal transduction
Process GO:0007176 Regulation of epidermal growth factor-activated receptor activity
Process GO:0007186 G protein-coupled receptor signaling pathway
Process GO:0007188 Adenylate cyclase-modulating G protein-coupled receptor signaling pathway
Process GO:0007189 Adenylate cyclase-activating G protein-coupled receptor signaling pathway
Process GO:0007193 Adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway
Process GO:0007200 Phospholipase C-activating G protein-coupled receptor signaling pathway
Process GO:0007565 Female pregnancy
Process GO:0007596 Blood coagulation
Process GO:0007599 Hemostasis
Process GO:0007600 Sensory perception
Process GO:0008015 Blood circulation
Process GO:0008152 Metabolic process
Process GO:0009611 Response to wounding
Process GO:0009719 Response to endogenous stimulus
Process GO:0009725 Response to hormone
Process GO:0009892 Negative regulation of metabolic process
Process GO:0009893 Positive regulation of metabolic process
Process GO:0009894 Regulation of catabolic process
Process GO:0009895 Negative regulation of catabolic process
Process GO:0009896 Positive regulation of catabolic process
Process GO:0009966 Regulation of signal transduction
Process GO:0009967 Positive regulation of signal transduction
Process GO:0009987 Cellular process
Process GO:0010033 Response to organic substance
Process GO:0010468 Regulation of gene expression
Process GO:0010469 Regulation of signaling receptor activity
Process GO:0010562 Positive regulation of phosphorus metabolic process
Process GO:0010604 Positive regulation of macromolecule metabolic process
Process GO:0010628 Positive regulation of gene expression
Process GO:0010646 Regulation of cell communication
Process GO:0010647 Positive regulation of cell communication
Process GO:0010648 Negative regulation of cell communication
Process GO:0010817 Regulation of hormone levels
Process GO:0017157 Regulation of exocytosis
Process GO:0017158 Regulation of calcium ion-dependent exocytosis
Process GO:0019216 Regulation of lipid metabolic process
Process GO:0019220 Regulation of phosphate metabolic process
Process GO:0019222 Regulation of metabolic process
Process GO:0019229 Regulation of vasoconstriction
Process GO:0022414 Reproductive process
Process GO:0023051 Regulation of signaling
Process GO:0023052 Signaling
Process GO:0023056 Positive regulation of signaling
Process GO:0023057 Negative regulation of signaling
Process GO:0030162 Regulation of proteolysis
Process GO:0030168 Platelet activation
Process GO:0030334 Regulation of cell migration
Process GO:0030335 Positive regulation of cell migration
Process GO:0031323 Regulation of cellular metabolic process
Process GO:0031325 Positive regulation of cellular metabolic process
Process GO:0031329 Regulation of cellular catabolic process
Process GO:0031331 Positive regulation of cellular catabolic process
Process GO:0031399 Regulation of protein modification process
Process GO:0031401 Positive regulation of protein modification process
Process GO:0032147 Activation of protein kinase activity
Process GO:0032148 Activation of protein kinase B activity
Process GO:0032501 Multicellular organismal process
Process GO:0032870 Cellular response to hormone stimulus
Process GO:0032879 Regulation of localization
Process GO:0032880 Regulation of protein localization
Process GO:0033500 Carbohydrate homeostasis
Process GO:0033555 Multicellular organismal response to stress
Process GO:0033674 Positive regulation of kinase activity
Process GO:0034641 Cellular nitrogen compound metabolic process
Process GO:0035150 Regulation of tube size
Process GO:0035296 Regulation of tube diameter
Process GO:0035624 Receptor transactivation
Process GO:0040012 Regulation of locomotion
Process GO:0040017 Positive regulation of locomotion
Process GO:0042058 Regulation of epidermal growth factor receptor signaling pathway
Process GO:0042060 Wound healing
Process GO:0042176 Regulation of protein catabolic process
Process GO:0042221 Response to chemical
Process GO:0042311 Vasodilation
Process GO:0042325 Regulation of phosphorylation
Process GO:0042327 Positive regulation of phosphorylation
Process GO:0042592 Homeostatic process
Process GO:0042593 Glucose homeostasis
Process GO:0042596 Fear response
Process GO:0043085 Positive regulation of catalytic activity
Process GO:0043170 Macromolecule metabolic process
Process GO:0043405 Regulation of MAP kinase activity
Process GO:0043406 Positive regulation of MAP kinase activity
Process GO:0043408 Regulation of MAPK cascade
Process GO:0043410 Positive regulation of MAPK cascade
Process GO:0043549 Regulation of kinase activity
Process GO:0044057 Regulation of system process
Process GO:0044093 Positive regulation of molecular function
Process GO:0044237 Cellular metabolic process
Process GO:0044238 Primary metabolic process
Process GO:0044260 Cellular macromolecule metabolic process
Process GO:0044703 Multi-organism reproductive process
Process GO:0044706 Multi-multicellular organism process
Process GO:0045732 Positive regulation of protein catabolic process
Process GO:0045741 Positive regulation of epidermal growth factor-activated receptor activity
Process GO:0045742 Positive regulation of epidermal growth factor receptor signaling pathway
Process GO:0045833 Negative regulation of lipid metabolic process
Process GO:0045859 Regulation of protein kinase activity
Process GO:0045860 Positive regulation of protein kinase activity
Process GO:0045862 Positive regulation of proteolysis
Process GO:0045920 Negative regulation of exocytosis
Process GO:0045932 Negative regulation of muscle contraction
Process GO:0045937 Positive regulation of phosphate metabolic process
Process GO:0045955 Negative regulation of calcium ion-dependent exocytosis
Process GO:0045986 Negative regulation of smooth muscle contraction
Process GO:0046483 Heterocycle metabolic process
Process GO:0046676 Negative regulation of insulin secretion
Process GO:0046883 Regulation of hormone secretion
Process GO:0046888 Negative regulation of hormone secretion
Process GO:0046928 Regulation of neurotransmitter secretion
Process GO:0048518 Positive regulation of biological process
Process GO:0048519 Negative regulation of biological process
Process GO:0048522 Positive regulation of cellular process
Process GO:0048523 Negative regulation of cellular process
Process GO:0048583 Regulation of response to stimulus
Process GO:0048584 Positive regulation of response to stimulus
Process GO:0048585 Negative regulation of response to stimulus
Process GO:0048878 Chemical homeostasis
Process GO:0050708 Regulation of protein secretion
Process GO:0050709 Negative regulation of protein secretion
Process GO:0050730 Regulation of peptidyl-tyrosine phosphorylation
Process GO:0050731 Positive regulation of peptidyl-tyrosine phosphorylation
Process GO:0050789 Regulation of biological process
Process GO:0050790 Regulation of catalytic activity
Process GO:0050794 Regulation of cellular process
Process GO:0050796 Regulation of insulin secretion
Process GO:0050804 Modulation of chemical synaptic transmission
Process GO:0050817 Coagulation
Process GO:0050877 Nervous system process
Process GO:0050878 Regulation of body fluid levels
Process GO:0050896 Response to stimulus
Process GO:0050951 Sensory perception of temperature stimulus
Process GO:0050955 Thermoception
Process GO:0050994 Regulation of lipid catabolic process
Process GO:0050995 Negative regulation of lipid catabolic process
Process GO:0051043 Regulation of membrane protein ectodomain proteolysis
Process GO:0051044 Positive regulation of membrane protein ectodomain proteolysis
Process GO:0051046 Regulation of secretion
Process GO:0051048 Negative regulation of secretion
Process GO:0051049 Regulation of transport
Process GO:0051051 Negative regulation of transport
Process GO:0051171 Regulation of nitrogen compound metabolic process
Process GO:0051173 Positive regulation of nitrogen compound metabolic process
Process GO:0051174 Regulation of phosphorus metabolic process
Process GO:0051223 Regulation of protein transport
Process GO:0051224 Negative regulation of protein transport
Process GO:0051239 Regulation of multicellular organismal process
Process GO:0051240 Positive regulation of multicellular organismal process
Process GO:0051241 Negative regulation of multicellular organismal process
Process GO:0051246 Regulation of protein metabolic process
Process GO:0051247 Positive regulation of protein metabolic process
Process GO:0051338 Regulation of transferase activity
Process GO:0051347 Positive regulation of transferase activity
Process GO:0051588 Regulation of neurotransmitter transport
Process GO:0051716 Cellular response to stimulus
Process GO:0060255 Regulation of macromolecule metabolic process
Process GO:0060341 Regulation of cellular localization
Process GO:0060627 Regulation of vesicle-mediated transport
Process GO:0061041 Regulation of wound healing
Process GO:0061097 Regulation of protein tyrosine kinase activity
Process GO:0061098 Positive regulation of protein tyrosine kinase activity
Process GO:0061178 Regulation of insulin secretion involved in cellular response to glucose stimulus
Process GO:0061179 Negative regulation of insulin secretion involved in cellular response to glucose stimulus
Process GO:0065007 Biological regulation
Process GO:0065008 Regulation of biological quality
Process GO:0065009 Regulation of molecular function
Process GO:0070201 Regulation of establishment of protein localization
Process GO:0070472 Regulation of uterine smooth muscle contraction
Process GO:0070473 Negative regulation of uterine smooth muscle contraction
Process GO:0070887 Cellular response to chemical stimulus
Process GO:0071310 Cellular response to organic substance
Process GO:0071495 Cellular response to endogenous stimulus
Process GO:0071704 Organic substance metabolic process
Process GO:0071875 Adrenergic receptor signaling pathway
Process GO:0071880 Adenylate cyclase-activating adrenergic receptor signaling pathway
Process GO:0071881 Adenylate cyclase-inhibiting adrenergic receptor signaling pathway
Process GO:0071882 Phospholipase C-activating adrenergic receptor signaling pathway
Process GO:0071900 Regulation of protein serine/threonine kinase activity
Process GO:0071902 Positive regulation of protein serine/threonine kinase activity
Process GO:0080090 Regulation of primary metabolic process
Process GO:0080134 Regulation of response to stress
Process GO:0090066 Regulation of anatomical structure size
Process GO:0090087 Regulation of peptide transport
Process GO:0090257 Regulation of muscle system process
Process GO:0090276 Regulation of peptide hormone secretion
Process GO:0090278 Negative regulation of peptide hormone secretion
Process GO:0090303 Positive regulation of wound healing
Process GO:0090304 Nucleic acid metabolic process
Process GO:0097746 Blood vessel diameter maintenance
Process GO:0099177 Regulation of trans-synaptic signaling
Process GO:1901184 Regulation of ERBB signaling pathway
Process GO:1901186 Positive regulation of ERBB signaling pathway
Process GO:1901360 Organic cyclic compound metabolic process
Process GO:1902531 Regulation of intracellular signal transduction
Process GO:1902533 Positive regulation of intracellular signal transduction
Process GO:1903034 Regulation of response to wounding
Process GO:1903036 Positive regulation of response to wounding
Process GO:1903305 Regulation of regulated secretory pathway
Process GO:1903306 Negative regulation of regulated secretory pathway
Process GO:1903522 Regulation of blood circulation
Process GO:1903530 Regulation of secretion by cell
Process GO:1903531 Negative regulation of secretion by cell
Process GO:1903828 Negative regulation of protein localization
Process GO:1904950 Negative regulation of establishment of protein localization
Process GO:2000145 Regulation of cell motility
Process GO:2000147 Positive regulation of cell motility
Process GO:2000273 Positive regulation of signaling receptor activity
Process GO:2000300 Regulation of synaptic vesicle exocytosis
Component GO:0005622 Intracellular anatomical structure
Component GO:0005737 Cytoplasm
Component GO:0005886 Plasma membrane
Component GO:0005887 Integral component of plasma membrane
Component GO:0014069 Postsynaptic density
Component GO:0016020 Membrane
Component GO:0016021 Integral component of membrane
Component GO:0030054 Cell junction
Component GO:0030424 Axon
Component GO:0031224 Intrinsic component of membrane
Component GO:0031226 Intrinsic component of plasma membrane
Component GO:0032279 Asymmetric synapse
Component GO:0032991 Protein-containing complex
Component GO:0036477 Somatodendritic compartment
Component GO:0042734 Presynaptic membrane
Component GO:0042995 Cell projection
Component GO:0043005 Neuron projection
Component GO:0043025 Neuronal cell body
Component GO:0043226 Organelle
Component GO:0043235 Receptor complex
Component GO:0043679 Axon terminus
Component GO:0044297 Cell body
Component GO:0044306 Neuron projection terminus
Component GO:0045202 Synapse
Component GO:0045211 Postsynaptic membrane
Component GO:0048786 Presynaptic active zone
Component GO:0048787 Presynaptic active zone membrane
Component GO:0071944 Cell periphery
Component GO:0097060 Synaptic membrane
Component GO:0098590 Plasma membrane region
Component GO:0098691 Dopaminergic synapse
Component GO:0098793 Presynapse
Component GO:0098794 Postsynapse
Component GO:0098839 Postsynaptic density membrane
Component GO:0098889 Intrinsic component of presynaptic membrane
Component GO:0098936 Intrinsic component of postsynaptic membrane
Component GO:0098945 Intrinsic component of presynaptic active zone membrane
Component GO:0098948 Intrinsic component of postsynaptic specialization membrane
Component GO:0098978 Glutamatergic synapse
Component GO:0098982 GABA-ergic synapse
Component GO:0098984 Neuron to neuron synapse
Component GO:0099055 Integral component of postsynaptic membrane
Component GO:0099056 Integral component of presynaptic membrane
Component GO:0099059 Integral component of presynaptic active zone membrane
Component GO:0099060 Integral component of postsynaptic specialization membrane
Component GO:0099061 Integral component of postsynaptic density membrane
Component GO:0099146 Intrinsic component of postsynaptic density membrane
Component GO:0099240 Intrinsic component of synaptic membrane
Component GO:0099572 Postsynaptic specialization
Component GO:0099634 Postsynaptic specialization membrane
Component GO:0099699 Integral component of synaptic membrane
Component GO:0110165 Cellular anatomical entity
Component GO:0120025 Plasma membrane bounded cell projection
Component GO:0150034 Distal axon
Function GO:0001664 G protein-coupled receptor binding
Function GO:0004888 Transmembrane signaling receptor activity
Function GO:0004930 G protein-coupled receptor activity
Function GO:0004935 Adrenergic receptor activity
Function GO:0004936 Alpha-adrenergic receptor activity
Function GO:0004938 alpha2-adrenergic receptor activity
Function GO:0005102 Signaling receptor binding
Function GO:0005488 Binding
Function GO:0005515 Protein binding
Function GO:0008227 G protein-coupled amine receptor activity
Function GO:0019899 Enzyme binding
Function GO:0019900 Kinase binding
Function GO:0019901 Protein kinase binding
Function GO:0031690 Adrenergic receptor binding
Function GO:0031696 alpha-2C adrenergic receptor binding
Function GO:0031996 Thioesterase binding
Function GO:0032795 Heterotrimeric G-protein binding
Function GO:0038023 Signaling receptor activity
Function GO:0042802 Identical protein binding
Function GO:0042803 Protein homodimerization activity
Function GO:0044877 Protein-containing complex binding
Function GO:0046982 Protein heterodimerization activity
Function GO:0046983 Protein dimerization activity
Function GO:0051379 Epinephrine binding
Function GO:0051380 Norepinephrine binding
Function GO:0060089 Molecular transducer activity
Function GO:0097159 Organic cyclic compound binding
Function GO:1901338 Catecholamine binding

Pathway annotation


Category Term ID Term description
RCTM RNO-109582 Hemostasis
RCTM RNO-1430728 Metabolism
RCTM RNO-162582 Signal Transduction
RCTM RNO-163685 Integration of energy metabolism
RCTM RNO-372790 Signaling by GPCR
RCTM RNO-373076 Class A/1 (Rhodopsin-like receptors)
RCTM RNO-375280 Amine ligand-binding receptors
RCTM RNO-388396 GPCR downstream signalling
RCTM RNO-390696 Adrenoceptors
RCTM RNO-392023 Adrenaline signalling through Alpha-2 adrenergic receptor
RCTM RNO-392499 Metabolism of proteins
RCTM RNO-400042 Adrenaline,noradrenaline inhibits insulin secretion
RCTM RNO-418594 G alpha (i) signalling events
RCTM RNO-418597 G alpha (z) signalling events
RCTM RNO-422356 Regulation of insulin secretion
RCTM RNO-500792 GPCR ligand binding
RCTM RNO-5683826 Surfactant metabolism
RCTM RNO-76002 Platelet activation, signaling and aggregation
RCTM RNO-76009 Platelet Aggregation (Plug Formation)
WikiPathways WP276 Monoamine GPCRs
WikiPathways WP473 GPCRs, class A rhodopsin-like

Expression profile of Adra2a in omics data



ID GSE100499
Title Exploring acupuncture mechanism in preconditioning of IRI
Organism Rattus norvegicus
GSM Sample info Characteristics Value
GSM2685201 MX1 tissue: Myocardium gender: male 2.3894625
GSM2685202 MX2 tissue: Myocardium gender: female 2.3464642
GSM2685203 MX3 tissue: Myocardium gender: female 2.3219392
GSM2685204 MX4 tissue: Myocardium gender: male 2.3913832
GSM2685205 DZ1 tissue: Myocardium gender: male 3.420829
GSM2685206 DZ2 tissue: Myocardium gender: male 3.2467592
GSM2685207 DZ3 tissue: Myocardium gender: female 2.457881
GSM2685208 DZ4 tissue: Myocardium gender: female 2.9356937
GSM2685209 JJ1 tissue: Myocardium gender: male 3.7769556
GSM2685210 JJ2 tissue: Myocardium gender: female 3.822151
GSM2685211 JJ3 tissue: Myocardium gender: female 3.6966584
GSM2685212 JJ4 tissue: Myocardium gender: male 3.0815544
GSM2685213 NG1 tissue: Myocardium gender: male 3.3371565
GSM2685214 NG2 tissue: Myocardium gender: female 3.2400482
GSM2685215 NG3 tissue: Myocardium gender: male 3.0852034
GSM2685216 NG4 tissue: Myocardium gender: female 3.0564046
GSM2685217 YL1 tissue: Myocardium gender: male 2.3701637
GSM2685218 YL2 tissue: Myocardium gender: male 2.740888
GSM2685219 YL3 tissue: Myocardium gender: female 2.5313566
GSM2685220 YL4 tissue: Myocardium gender: female 2.5710938
GSM2685221 QC1 tissue: Myocardium gender: male 2.4375904
GSM2685222 QC2 tissue: Myocardium gender: male 3.7394507
GSM2685223 QC3 tissue: Myocardium gender: female 3.4279664
GSM2685224 QC4 tissue: Myocardium gender: female 3.1653671

ID GSE136833
Title Effects of lidocaine on the expression of rat spinal cord
Organism Rattus norvegicus
GSM Sample info Characteristics Value
GSM4058984 Control_1 strain: Sprague-Dawley tissue: Lumbar segment of spinal cord 5.157821277
GSM4058985 Control_2 strain: Sprague-Dawley tissue: Lumbar segment of spinal cord 5.31247856
GSM4058986 Control_3 strain: Sprague-Dawley tissue: Lumbar segment of spinal cord 5.230199387
GSM4058987 Lidocaine_1 strain: Sprague-Dawley tissue: Lumbar segment of spinal cord 4.999867655
GSM4058988 Lidocaine_2 strain: Sprague-Dawley tissue: Lumbar segment of spinal cord 4.875092994
GSM4058989 Lidocaine_3 strain: Sprague-Dawley tissue: Lumbar segment of spinal cord 4.696371335

ID GSE138454
Title Impact of inflammation on hepatic subcellular energetics in anesthetized rats
Organism Rattus norvegicus
GSM Sample info Characteristics Value
GSM4108997 Sample 1 Isoflurane sepsis anesthetic background: Isoflurane strain: Sprague-Dawley age: 10 weeks old sepsis/control: sepsis gender: male 1.0
GSM4108998 Sample 2 Isoflurane sepsis anesthetic background: Isoflurane strain: Sprague-Dawley age: 10 weeks old sepsis/control: sepsis gender: male 2.0
GSM4108999 Sample 3 Isoflurane sepsis anesthetic background: Isoflurane strain: Sprague-Dawley age: 10 weeks old sepsis/control: sepsis gender: male 3.0
GSM4109000 Sample 4 Isoflurane sepsis anesthetic background: Isoflurane strain: Sprague-Dawley age: 10 weeks old sepsis/control: sepsis gender: male 0.0
GSM4109001 Sample 5 Isoflurane control anesthetic background: Isoflurane strain: Sprague-Dawley age: 10 weeks old sepsis/control: control gender: male 1.0
GSM4109002 Sample 6 Isoflurane control anesthetic background: Isoflurane strain: Sprague-Dawley age: 10 weeks old sepsis/control: control gender: male 0.0
GSM4109003 Sample 7 Isoflurane control anesthetic background: Isoflurane strain: Sprague-Dawley age: 10 weeks old sepsis/control: control gender: male 0.0
GSM4109004 Sample 8 Isoflurane control anesthetic background: Isoflurane strain: Sprague-Dawley age: 10 weeks old sepsis/control: control gender: male 1.0
GSM4109005 Sample9 Propofol sepsis anesthetic background: Propofol strain: Sprague-Dawley age: 10 weeks old sepsis/control: sepsis gender: male 3.0
GSM4109006 Sample10 Propofol sepsis anesthetic background: Propofol strain: Sprague-Dawley age: 10 weeks old sepsis/control: sepsis gender: male 2.0
GSM4109007 Sample11 Propofol sepsis anesthetic background: Propofol strain: Sprague-Dawley age: 10 weeks old sepsis/control: sepsis gender: male 2.0
GSM4109008 Sample12 Propofol sepsis anesthetic background: Propofol strain: Sprague-Dawley age: 10 weeks old sepsis/control: sepsis gender: male 4.0
GSM4109009 Sample13 Propofol control anesthetic background: Propofol strain: Sprague-Dawley age: 10 weeks old sepsis/control: control gender: male 0.0
GSM4109010 Sample14 Propofol control anesthetic background: Propofol strain: Sprague-Dawley age: 10 weeks old sepsis/control: control gender: male 0.0
GSM4109011 Sample 15 Propofol control anesthetic background: Propofol strain: Sprague-Dawley age: 10 weeks old sepsis/control: control gender: male 0.0
GSM4109012 Sample16 Propofol control anesthetic background: Propofol strain: Sprague-Dawley age: 10 weeks old sepsis/control: control gender: male 2.0

ID GSE139220
Title Expression data from sevoflurane anesthesia treated rat
Organism Rattus norvegicus
GSM Sample info Characteristics Value
GSM4134285 Brain_Control_rep1 strain: Sprague-Dawley age: 18-month old treatment: control tissue: hippocampus 6.173923
GSM4134286 Brain_Control_rep2 strain: Sprague-Dawley age: 18-month old treatment: control tissue: hippocampus 6.475932
GSM4134287 Brain_Control_rep3 strain: Sprague-Dawley age: 18-month old treatment: control tissue: hippocampus 6.294278
GSM4134288 Brain_Sevoflurane_rep1 strain: Sprague-Dawley age: 18-month old treatment: sevoflurane anesthesia tissue: hippocampus 6.320324
GSM4134289 Brain_Sevoflurane_rep2 strain: Sprague-Dawley age: 18-month old treatment: sevoflurane anesthesia tissue: hippocampus 6.36295
GSM4134290 Brain_Sevoflurane_rep3 strain: Sprague-Dawley age: 18-month old treatment: sevoflurane anesthesia tissue: hippocampus 6.420035

ID GSE143895
Title GPR160 de-orphanization reveals critical roles in neuropathic pain in rodents
Organism Rattus norvegicus
GSM Sample info Characteristics Value
GSM4276356 dhsc01 strain: Sprague Dawley tissue: DHSC treatment: CCI 10.025
GSM4276357 dhsc03 strain: Sprague Dawley tissue: DHSC treatment: CCI 11.339
GSM4276358 dhsc05 strain: Sprague Dawley tissue: DHSC treatment: CCI 11.864
GSM4276359 dhsc13 strain: Sprague Dawley tissue: DHSC treatment: SHAM 9.308
GSM4276360 dhsc15 strain: Sprague Dawley tissue: DHSC treatment: SHAM 11.555

ID GSE157924
Title Regulation of acupuncture on genes in brain stem
Organism Rattus norvegicus
GSM Sample info Characteristics Value
GSM4780973 Rattus_JSSZ(Sham) tissue: Rattus brainstem of modeling treatment: Sham 7.0330054104999995
GSM4780974 Rattus_JXZ(Hand Acu) tissue: Rattus brainstem of modeling treatment: Hand Acu 6.932685150499999
GSM4780975 Rattus_MXZ(TBI) tissue: Rattus brainstem of modeling treatment: TBI 7.1968353

ID GSE1616
Title Genomics of preconditioning
Organism Rattus norvegicus
GSM Sample info Characteristics Value
GSM27484 APC_a (anesthetic-preconditioning, 1st replicate) 191.73333333333335
GSM27485 APC_b (anesthetic-preconditioning, 2nd replicate) 164.66666666666666
GSM27486 APC_c (anesthetic-preconditioning, 3rd replicate) 196.86666666666667
GSM27487 APC_d (anesthetic-preconditioning, 4th replicate) 187.9333333333333
GSM27488 APC_e (anesthetic-preconditioning, 5th replicate) 120.90000000000002
GSM27489 APC_TRI_a (trigger of anesthetic-preconditioning, 1st replicate) 227.13333333333333
GSM27490 APC_TRI_b (trigger of anesthetic-preconditioning, 2nd replicate) 143.89999999999998
GSM27491 APC_TRI_c (trigger of anesthetic-preconditioning, 3rd replicate) 208.4
GSM27492 APC_TRI_d (trigger of anesthetic-preconditioning, 4th replicate) 177.9333333333333
GSM27493 APC_TRI_e (trigger of anesthetic-preconditioning, 5th replicate) 135.6
GSM27494 CTL_a (control, 1st replicate) 171.6
GSM27495 CTL_b (control, 2nd replicate) 132.16666666666666
GSM27496 CTL_c (control, 3rd replicate) 205.83333333333334
GSM27497 CTL_d (control, 4th replicate) 155.76666666666668
GSM27498 CTL_e (control, 5th replicate) 149.9
GSM27499 IPC_a (ischemic preconditioning, 1st replicate) 181.86666666666667
GSM27500 IPC_b (ischemic preconditioning, 2nd replicate) 131.7
GSM27501 IPC_c (ischemic preconditioning, 3rd replicate) 132.9
GSM27502 IPC_d (ischemic preconditioning, 4th replicate) 146.23333333333332
GSM27503 IPC_e (ischemic preconditioning, 5th replicate) 182.23333333333335
GSM27504 IPC_TRI_a (trigger of ischemic preconditioning, 1st replicate) 242.4333333333333
GSM27505 IPC_TRI_b (trigger of ischemic preconditioning, 2nd replicate) 223.29999999999998
GSM27506 IPC_TRI_c (trigger of ischemic preconditioning, 3rd replicate) 132.06666666666666
GSM27507 IPC_TRI_d (trigger of ischemic preconditioning, 4th replicate) 139.20000000000002
GSM27508 IPC_TRI_e (trigger of ischemic preconditioning, 5th replicate) 222.0666666666667
GSM27509 ISCH_a (ischemia, 1st replicate) 170.89999999999998
GSM27510 ISCH_b (ischemia, 2nd replicate) 150.13333333333333
GSM27511 ISCH_c (ischemia, 3rd replicate) 222.10000000000002
GSM27512 ISCH_d (ischemia, 4th replicate) 202.83333333333334
GSM27513 ISCH_e (ischemia, 5th replicate) 174.76666666666668

ID GSE1779
Title Effect of Isoflurane and LTM on basolateral amygdala
Organism Rattus norvegicus
GSM Sample info Characteristics Value
GSM30790 baseline control 01 male, 275-300g 95.6
GSM30791 baseline control 02 male, 275-300g 83.7
GSM30792 baseline control 03 male, 275-300g 112.1
GSM30793 baseline control 04 male, 275-300g 119.0
GSM30794 baseline control 05 male, 275-300g 130.4
GSM30795 baseline control 06 male, 275-300g 117.1
GSM30796 baseline control 07 male, 275-300g 132.4
GSM30797 baseline control 08 male, 275-300g 98.1
GSM30798 baseline control 09 male, 275-300g 134.6
GSM30799 pain 01 73.6
GSM30800 pain 02 130.2
GSM30801 pain 03 66.5
GSM30802 pain 04 133.9
GSM30803 pain 05 36.5
GSM30804 FC 01 196.2
GSM30805 FC 02 132.4
GSM30806 FC 03 130.3
GSM30807 FC 04 95.7
GSM30808 FC 05 64.0
GSM30809 IFC 01 105.7
GSM30810 IFC 02 60.6
GSM30811 IFC 03 130.2
GSM30812 IFC 04 96.9
GSM30813 IFC 05 143.0
GSM99800 isoflurane 01 male, 275-300g 165.7
GSM99801 isoflurane 02 male, 275-300g 95.8
GSM99802 isoflurane 03 male, 275-300g 123.8
GSM99803 isoflurane 04 male, 275-300g 108.7
GSM99804 isoflurane 05 male, 275-300g 73.2

ID GSE190472
Title Study on VEGF regulation mechanism of acupuncture improving endometrial receptivity in IVF-ET
Organism Rattus norvegicus
GSM Sample info Characteristics Value
GSM5724271 model 21 Sex: female tissue: Uterine tissue condition: model 14.76315
GSM5724272 model 22 Sex: female tissue: Uterine tissue condition: model 14.0412
GSM5724273 model 23 Sex: female tissue: Uterine tissue condition: model 13.075050000000001
GSM5724274 treatment31 Sex: female tissue: Uterine tissue condition: treatment 13.1329
GSM5724275 treatment32 Sex: female tissue: Uterine tissue condition: treatment 9.1786
GSM5724276 treatment33 Sex: female tissue: Uterine tissue condition: treatment 15.2091
GSM5724277 control 41 Sex: female tissue: Uterine tissue condition: control 13.558900000000001
GSM5724278 control 42 Sex: female tissue: Uterine tissue condition: control 14.02595
GSM5724279 control 43 Sex: female tissue: Uterine tissue condition: control 19.034599999999998

ID GSE192399
Title Gene expression of brain regions activated by sevoflurane and propofol
Organism Rattus norvegicus
GSM Sample info Characteristics Value
GSM5746332 LHb, Sevoflurane, 60mins brain region: the lateral habenula (LHb) treatment: Sevoflurane 6.61081
GSM5746333 LHb, O2, 60mins brain region: the lateral habenula (LHb) treatment: O2 6.64471
GSM5746334 MHb, Sevoflurane, 60mins brain region: the medial habenula (MHb) treatment: Sevoflurane 5.99688
GSM5746335 MHb, O2, 60mins brain region: the medial habenula (MHb) treatment: O2 6.37744
GSM5746336 Sol, Sevoflurane, 60mins brain region: the solitary nucleus (Sol) treatment: Sevoflurane 9.07903
GSM5746337 Sol, O2, 60mins brain region: the solitary nucleus (Sol) treatment: O2 9.54841
GSM5746338 Mve, Sevoflurane, 60mins brain region: the medial vestibular nucleus (MVe) treatment: Sevoflurane 6.82453
GSM5746339 Mve, O2, 60mins brain region: the medial vestibular nucleus (MVe) treatment: O2 6.50002
GSM5746340 LHb, Propofol, 60mins brain region: the lateral habenula (LHb) treatment: Propofol 7.12542
GSM5746341 LHb, Intralipos, 60mins brain region: the lateral habenula (LHb) treatment: Intralipos 6.63958
GSM5746342 MHb, Propofol, 60mins brain region: the medial habenula (MHb) treatment: Propofol 5.60536
GSM5746343 MHb, Intralipos, 60mins brain region: the medial habenula (MHb) treatment: Intralipos 6.69193
GSM5746344 Sol, Propofol, 60mins brain region: the solitary nucleus (Sol) treatment: Propofol 8.64349
GSM5746345 Sol, Intralipos, 60mins brain region: the solitary nucleus (Sol) treatment: Intralipos 8.68846
GSM5746346 MVe, Propofol, 60mins brain region: the medial vestibular nucleus (MVe) treatment: Propofol 6.07373
GSM5746347 MVe, Intralipos, 60mins brain region: the medial vestibular nucleus (MVe) treatment: Intralipos 6.41143

ID GSE205202
Title Hepatic responses of mice and rats to equivalent acetaminophen (APAP) insult [rat]
Organism Rattus norvegicus
GSM Sample info Characteristics Value
GSM6208507 Rat_Baseline_0h_1 tissue: liver strain: Sprague-Dawley Sex: male treatment: Untreated hours after treatment: 0 4.680133
GSM6208508 Rat_Baseline_0h_2 tissue: liver strain: Sprague-Dawley Sex: male treatment: Untreated hours after treatment: 0 4.983614
GSM6208509 Rat_Baseline_0h_3 tissue: liver strain: Sprague-Dawley Sex: male treatment: Untreated hours after treatment: 0 4.747572
GSM6208510 Rat_Baseline_0h_4 tissue: liver strain: Sprague-Dawley Sex: male treatment: Untreated hours after treatment: 0 4.702293
GSM6208511 Rat_Baseline_0h_5 tissue: liver strain: Sprague-Dawley Sex: male treatment: Untreated hours after treatment: 0 4.763308
GSM6208512 Rat_Vehicle_03h_1 tissue: liver strain: Sprague-Dawley Sex: male treatment: Vehicle (1% [w/v] hydroxyethylcellulose, o.g.) hours after treatment: 3 4.704624
GSM6208513 Rat_Vehicle_03h_2 tissue: liver strain: Sprague-Dawley Sex: male treatment: Vehicle (1% [w/v] hydroxyethylcellulose, o.g.) hours after treatment: 3 4.719124
GSM6208514 Rat_Vehicle_03h_3 tissue: liver strain: Sprague-Dawley Sex: male treatment: Vehicle (1% [w/v] hydroxyethylcellulose, o.g.) hours after treatment: 3 4.646855
GSM6208515 Rat_Vehicle_03h_4 tissue: liver strain: Sprague-Dawley Sex: male treatment: Vehicle (1% [w/v] hydroxyethylcellulose, o.g.) hours after treatment: 3 4.849424
GSM6208516 Rat_Vehicle_03h_5 tissue: liver strain: Sprague-Dawley Sex: male treatment: Vehicle (1% [w/v] hydroxyethylcellulose, o.g.) hours after treatment: 3 4.597331
GSM6208517 Rat_Vehicle_06h_1 tissue: liver strain: Sprague-Dawley Sex: male treatment: Vehicle (1% [w/v] hydroxyethylcellulose, o.g.) hours after treatment: 6 4.709932
GSM6208518 Rat_Vehicle_06h_2 tissue: liver strain: Sprague-Dawley Sex: male treatment: Vehicle (1% [w/v] hydroxyethylcellulose, o.g.) hours after treatment: 6 4.803406
GSM6208519 Rat_Vehicle_06h_3 tissue: liver strain: Sprague-Dawley Sex: male treatment: Vehicle (1% [w/v] hydroxyethylcellulose, o.g.) hours after treatment: 6 4.706889
GSM6208520 Rat_Vehicle_06h_4 tissue: liver strain: Sprague-Dawley Sex: male treatment: Vehicle (1% [w/v] hydroxyethylcellulose, o.g.) hours after treatment: 6 4.678119
GSM6208521 Rat_Vehicle_06h_5 tissue: liver strain: Sprague-Dawley Sex: male treatment: Vehicle (1% [w/v] hydroxyethylcellulose, o.g.) hours after treatment: 6 4.768858
GSM6208522 Rat_Vehicle_09h_1 tissue: liver strain: Sprague-Dawley Sex: male treatment: Vehicle (1% [w/v] hydroxyethylcellulose, o.g.) hours after treatment: 9 4.822509
GSM6208523 Rat_Vehicle_09h_2 tissue: liver strain: Sprague-Dawley Sex: male treatment: Vehicle (1% [w/v] hydroxyethylcellulose, o.g.) hours after treatment: 9 4.714434
GSM6208524 Rat_Vehicle_09h_3 tissue: liver strain: Sprague-Dawley Sex: male treatment: Vehicle (1% [w/v] hydroxyethylcellulose, o.g.) hours after treatment: 9 4.749447
GSM6208525 Rat_Vehicle_09h_4 tissue: liver strain: Sprague-Dawley Sex: male treatment: Vehicle (1% [w/v] hydroxyethylcellulose, o.g.) hours after treatment: 9 4.750418
GSM6208526 Rat_Vehicle_09h_5 tissue: liver strain: Sprague-Dawley Sex: male treatment: Vehicle (1% [w/v] hydroxyethylcellulose, o.g.) hours after treatment: 9 4.691666
GSM6208527 Rat_Vehicle_24h_1 tissue: liver strain: Sprague-Dawley Sex: male treatment: Vehicle (1% [w/v] hydroxyethylcellulose, o.g.) hours after treatment: 24 4.814367
GSM6208528 Rat_Vehicle_24h_2 tissue: liver strain: Sprague-Dawley Sex: male treatment: Vehicle (1% [w/v] hydroxyethylcellulose, o.g.) hours after treatment: 24 4.724618
GSM6208529 Rat_Vehicle_24h_3 tissue: liver strain: Sprague-Dawley Sex: male treatment: Vehicle (1% [w/v] hydroxyethylcellulose, o.g.) hours after treatment: 24 4.797272
GSM6208530 Rat_Vehicle_24h_4 tissue: liver strain: Sprague-Dawley Sex: male treatment: Vehicle (1% [w/v] hydroxyethylcellulose, o.g.) hours after treatment: 24 4.862624
GSM6208531 Rat_Vehicle_24h_5 tissue: liver strain: Sprague-Dawley Sex: male treatment: Vehicle (1% [w/v] hydroxyethylcellulose, o.g.) hours after treatment: 24 4.695301
GSM6208532 Rat_APAP_03h_1 tissue: liver strain: Sprague-Dawley Sex: male treatment: 1000 mg/kg acetamnophen (o.g.) hours after treatment: 3 4.752878
GSM6208533 Rat_APAP_03h_2 tissue: liver strain: Sprague-Dawley Sex: male treatment: 1000 mg/kg acetamnophen (o.g.) hours after treatment: 3 5.021376
GSM6208534 Rat_APAP_03h_3 tissue: liver strain: Sprague-Dawley Sex: male treatment: 1000 mg/kg acetamnophen (o.g.) hours after treatment: 3 4.746375
GSM6208535 Rat_APAP_03h_4 tissue: liver strain: Sprague-Dawley Sex: male treatment: 1000 mg/kg acetamnophen (o.g.) hours after treatment: 3 4.827261
GSM6208536 Rat_APAP_03h_5 tissue: liver strain: Sprague-Dawley Sex: male treatment: 1000 mg/kg acetamnophen (o.g.) hours after treatment: 3 4.829198
GSM6208537 Rat_APAP_06h_1 tissue: liver strain: Sprague-Dawley Sex: male treatment: 1000 mg/kg acetamnophen (o.g.) hours after treatment: 6 4.77789
GSM6208538 Rat_APAP_06h_2 tissue: liver strain: Sprague-Dawley Sex: male treatment: 1000 mg/kg acetamnophen (o.g.) hours after treatment: 6 4.77789
GSM6208539 Rat_APAP_06h_3 tissue: liver strain: Sprague-Dawley Sex: male treatment: 1000 mg/kg acetamnophen (o.g.) hours after treatment: 6 4.98197
GSM6208540 Rat_APAP_06h_4 tissue: liver strain: Sprague-Dawley Sex: male treatment: 1000 mg/kg acetamnophen (o.g.) hours after treatment: 6 4.744068
GSM6208541 Rat_APAP_06h_5 tissue: liver strain: Sprague-Dawley Sex: male treatment: 1000 mg/kg acetamnophen (o.g.) hours after treatment: 6 4.980434
GSM6208542 Rat_APAP_09h_1 tissue: liver strain: Sprague-Dawley Sex: male treatment: 1000 mg/kg acetamnophen (o.g.) hours after treatment: 9 4.834531
GSM6208543 Rat_APAP_09h_2 tissue: liver strain: Sprague-Dawley Sex: male treatment: 1000 mg/kg acetamnophen (o.g.) hours after treatment: 9 4.767822
GSM6208544 Rat_APAP_09h_3 tissue: liver strain: Sprague-Dawley Sex: male treatment: 1000 mg/kg acetamnophen (o.g.) hours after treatment: 9 4.822566
GSM6208545 Rat_APAP_09h_4 tissue: liver strain: Sprague-Dawley Sex: male treatment: 1000 mg/kg acetamnophen (o.g.) hours after treatment: 9 4.827794
GSM6208546 Rat_APAP_09h_5 tissue: liver strain: Sprague-Dawley Sex: male treatment: 1000 mg/kg acetamnophen (o.g.) hours after treatment: 9 4.902211
GSM6208547 Rat_APAP_24h_1 tissue: liver strain: Sprague-Dawley Sex: male treatment: 1000 mg/kg acetamnophen (o.g.) hours after treatment: 24 4.896192
GSM6208548 Rat_APAP_24h_2 tissue: liver strain: Sprague-Dawley Sex: male treatment: 1000 mg/kg acetamnophen (o.g.) hours after treatment: 24 4.86878
GSM6208549 Rat_APAP_24h_3 tissue: liver strain: Sprague-Dawley Sex: male treatment: 1000 mg/kg acetamnophen (o.g.) hours after treatment: 24 4.764463
GSM6208550 Rat_APAP_24h_4 tissue: liver strain: Sprague-Dawley Sex: male treatment: 1000 mg/kg acetamnophen (o.g.) hours after treatment: 24 4.795932
GSM6208551 Rat_APAP_24h_5 tissue: liver strain: Sprague-Dawley Sex: male treatment: 1000 mg/kg acetamnophen (o.g.) hours after treatment: 24 4.852301

ID GSE232804
Title EGR3 regulates opioid-related nociception and motivation in male rats
Organism Rattus norvegicus
GSM Sample info Characteristics Value
GSM7383519 ww01_Saline_Saline tissue: Brain / mPFC pain: Saline drug: Salin 62.0
GSM7383520 ww02_Saline_Saline tissue: Brain / mPFC pain: Saline drug: Saline 74.0
GSM7383521 ww03_Saline_Saline tissue: Brain / mPFC pain: Saline drug: Salin 57.0
GSM7383522 ww05_Saline_Saline tissue: Brain / mPFC pain: Saline drug: Saline 89.0
GSM7383523 ww06_Saline_Saline tissue: Brain / mPFC pain: Saline drug: Salin 81.0
GSM7383524 ww07_Saline_Saline tissue: Brain / mPFC pain: Saline drug: Saline 82.0
GSM7383525 ww08_Saline_Saline tissue: Brain / mPFC pain: Saline drug: Salin 71.0
GSM7383526 ww10_Saline_Saline tissue: Brain / mPFC pain: Saline drug: Saline 98.0
GSM7383527 ww12_Saline_OXY tissue: Brain / mPFC pain: Saline drug: OXY 87.0
GSM7383528 ww13_Saline_OXY tissue: Brain / mPFC pain: Saline drug: OXY 150.0
GSM7383529 ww14_Saline_OXY tissue: Brain / mPFC pain: Saline drug: OXY 76.0
GSM7383530 ww15_Saline_OXY tissue: Brain / mPFC pain: Saline drug: OXY 99.0
GSM7383531 ww16_Saline_OXY tissue: Brain / mPFC pain: Saline drug: OXY 101.0
GSM7383532 ww17_Saline_OXY tissue: Brain / mPFC pain: Saline drug: OXY 141.0
GSM7383533 ww18_Saline_OXY tissue: Brain / mPFC pain: Saline drug: OXY 123.0
GSM7383534 ww20_Saline_OXY tissue: Brain / mPFC pain: Saline drug: OXY 70.0
GSM7383535 ww21_CFA_Saline tissue: Brain / mPFC pain: CFA drug: Saline 114.0
GSM7383536 ww22_CFA_Saline tissue: Brain / mPFC pain: CFA drug: Saline 95.0
GSM7383537 ww23_CFA_Saline tissue: Brain / mPFC pain: CFA drug: Saline 101.0
GSM7383538 ww24_CFA_Saline tissue: Brain / mPFC pain: CFA drug: Saline 57.0
GSM7383539 ww26_CFA_Saline tissue: Brain / mPFC pain: CFA drug: Saline 110.0
GSM7383540 ww27_CFA_Saline tissue: Brain / mPFC pain: CFA drug: Saline 124.0
GSM7383541 ww28_CFA_Saline tissue: Brain / mPFC pain: CFA drug: Saline 96.0
GSM7383542 ww30_CFA_Saline tissue: Brain / mPFC pain: CFA drug: Saline 104.0
GSM7383543 ww31_CFA_OXY tissue: Brain / mPFC pain: CFA drug: OXY 121.0
GSM7383544 ww32_CFA_OXY tissue: Brain / mPFC pain: CFA drug: OXY 75.0
GSM7383545 ww34_CFA_OXY tissue: Brain / mPFC pain: CFA drug: OXY 93.0
GSM7383546 ww35_CFA_OXY tissue: Brain / mPFC pain: CFA drug: OXY 96.0
GSM7383547 ww36_CFA_OXY tissue: Brain / mPFC pain: CFA drug: OXY 134.0
GSM7383548 ww37_CFA_OXY tissue: Brain / mPFC pain: CFA drug: OXY 88.0
GSM7383549 ww38_CFA_OXY tissue: Brain / mPFC pain: CFA drug: OXY 72.0
GSM7383550 www09_Saline_Saline tissue: Brain / mPFC pain: Saline drug: Saline 119.0
GSM7383551 www19_Saline_OXY tissue: Brain / mPFC pain: Saline drug: OXY 112.0
GSM7383552 www29_CFA_Saline tissue: Brain / mPFC pain: CFA drug: Saline 90.0
GSM7383553 www33_CFA_OXY tissue: Brain / mPFC pain: CFA drug: OXY 88.0
GSM7383554 www39_CFA_OXY tissue: Brain / mPFC pain: CFA drug: OXY 86.0

ID GSE244436
Title Similarity and dissimilarity in alteration of gene expression profile associated with inhalational anesthesia between sevoflurane and desflurane
Organism Rattus norvegicus
GSM Sample info Characteristics Value
GSM7816143 Liver, Control for SevoAnes tissue: liver genotype: wild type treatment: Control for SevoAnes 0.0
GSM7816144 Liver, Anesthetized with sevoflurane for 6 h tissue: liver genotype: wild type treatment: Anesthetized with sevoflurane for 6 h 0.0
GSM7816145 Liver, Control for DesAnes tissue: liver genotype: wild type treatment: Control for DesAnes 0.038513
GSM7816146 Liver, Anesthetized with desflurane for 6 h tissue: liver genotype: wild type treatment: Anesthetized with desflurane for 6 h 0.0

ID GSE2982
Title Effect of inhaled anesthetic to cultured cortical neurons
Organism Rattus norvegicus
GSM Sample info Characteristics Value
GSM61779 Cell Culture Exposure (control1) Cy3 label;Cy5; -0.0239
GSM61796 Cell Culture Exposure (control2) Cy3; Cy5 -0.0352
GSM61797 Cell Culture Exposure (control3) Cy3; Cy5 -0.0558
GSM61798 Cell Culture Exposure (1MAC Halo1) Cy3; Cy5 0.263
GSM61799 Cell Culture Exposure (1MAC Halo2) Cy3; Cy5 -0.088
GSM61800 Cell Culture Exposure (1MAC Halo3) Cy3; Cy5 -0.0576
GSM61801 Cell Culture Exposure (3MAC Halo1) Cy3; Cy5 -0.0758
GSM61802 Cell Culture Exposure (3MAC Halo2) Cy3; Cy5 -0.0248
GSM61803 Cell Culture Exposure (3MAC Halo3) Cy3; Cy5 -0.117
GSM61804 Cell Culture Exposure (3MAC ISO1) Cy3; Cy5 -0.092
GSM61805 Cell Culture Exposure (3MAC ISO2) Cy3; Cy5 -0.13
GSM61806 Cell Culture Exposure (3MAC ISO3) Cy3; Cy5 -0.0498

ID GSE359
Title Isoflurane Single Exposures
Organism Rattus norvegicus
GSM Sample info Characteristics Value
GSM5120 Isoflurane single exposure control-1 36.13333333333333
GSM5121 Isoflurane single exposure control-2 40.599999999999994
GSM5122 Isoflurane single exposure control-3 39.73333333333333
GSM5124 Isoflurane single exposure 1 hr-1 41.73333333333334
GSM5126 Isoflurane single exposure 1 hr-2 56.76666666666666
GSM5127 Isoflurane single exposure 2 hr-1 42.800000000000004
GSM5130 Isoflurane single exposure 2 hr-2 63.93333333333334
GSM5131 Isoflurane single exposure 2 hr-3 32.199999999999996

ID GSE48025
Title Affymetrix Chip Data of the Transcriptome of the Rheumatoid Arthritis Rat Model Treated with Acupuncture (Affymetrix, mRNA, batch1)
Organism Rattus norvegicus
GSM Sample info Characteristics Value
GSM1165929 RAT_NORA_T0_1 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: healthy rats before therapy 3.626232605
GSM1165930 RAT_NORA_T0_2 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: healthy rats before therapy 3.4452183290000002
GSM1165931 RAT_RA_T0_1 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats before therapy 3.618621151
GSM1165932 RAT_RA_T0_2 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats before therapy 3.3902439375
GSM1165933 RAT_NORA_1h_1 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: healthy rats at 1 hour after therapy 3.4044192385
GSM1165934 RAT_NORA_1h_2 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: healthy rats at 1 hour after therapy 3.5186980525
GSM1165935 RAT_AP_1h_1 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 1 hour acupuncture therapy 3.6214350494999996
GSM1165936 RAT_AP_1h_2 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 1 hour acupuncture therapy 3.5573432929999997
GSM1165937 RAT_MTX_1h_1 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 1 hour MTX therapy 3.508356752
GSM1165938 RAT_MTX_1h_2 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 1 hour MTX therapy 3.449353157
GSM1165939 RAT_ANE_1h_1 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 1 hour ANE therapy 3.5669632785000003
GSM1165940 RAT_ANE_1h_2 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 1 hour ANE therapy 3.6663278205
GSM1165941 RAT_PLA_1h_1 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 1 hour placebo therapy 3.5410009794999997
GSM1165942 RAT_PLA_1h_2 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 1 hour placebo therapy 3.5825212889999998
GSM1165943 RAT_NORA_34d_1 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: healthy rats at 34 days after therapy 3.5633273465
GSM1165944 RAT_NORA_34d_2 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: healthy rats at 34 days after therapy 3.751248308
GSM1165945 RAT_AP_34d_1 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 34 days acupuncture therapy 3.964801006
GSM1165946 RAT_AP_34d_2 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 34 days acupuncture therapy 3.546411864
GSM1165947 RAT_MTX_34d_1 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 34 days MTX therapy 3.5459795105
GSM1165948 RAT_MTX_34d_2 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 34 days MTX therapy 3.7472863045
GSM1165949 RAT_ANE_34d_1 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 34 days ANE therapy 3.740013201
GSM1165950 RAT_ANE_34d_2 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 34 days ANE therapy 3.665898802
GSM1165951 RAT_PLA_34d_1 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 34 days placebo therapy 3.6172284325
GSM1165952 RAT_PLA_34d_2 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 34 days placebo therapy 3.529995739

ID GSE58456
Title Affymetrix Chip Data of the Transcriptome of the Rheumatoid Arthritis Rat Model Treated with Acupuncture (Affymetrix, mRNA, batch 2)
Organism Rattus norvegicus
GSM Sample info Characteristics Value
GSM1693996 Peripheral blood mononuclear cells from NORA before therapy, replicate 1 strain/background: Wistar gender: female cell type: peripheral blood mononuclear cells subject group: healthy rats before therapy 4.5598524005
GSM1693997 Peripheral blood mononuclear cells from NORA before therapy, replicate 2 strain/background: Wistar gender: female cell type: peripheral blood mononuclear cells subject group: healthy rats before therapy 20.264343716
GSM1693998 Peripheral blood mononuclear cells from NORA before therapy, replicate 3 strain/background: Wistar gender: female cell type: peripheral blood mononuclear cells subject group: healthy rats before therapy 47.7512115775
GSM1693999 Peripheral blood mononuclear cells from RA before therapy, replicate 1 strain/background: Wistar gender: female cell type: peripheral blood mononuclear cells subject group: rheumatoid arthritis rats before therapy 26.159692470000003
GSM1694000 Peripheral blood mononuclear cells from RA before therapy, replicate 2 strain/background: Wistar gender: female cell type: peripheral blood mononuclear cells subject group: rheumatoid arthritis rats before therapy 10.142869801
GSM1694001 Peripheral blood mononuclear cells from HAP after 34 days acupuncture therapy, replicate 1 strain/background: Wistar gender: female cell type: peripheral blood mononuclear cells subject group: healthy rats after 34 days acupuncture therapy 35.9991532505
GSM1694002 Peripheral blood mononuclear cells from HAP after 34 days acupuncture therapy, replicate 2 strain/background: Wistar gender: female cell type: peripheral blood mononuclear cells subject group: healthy rats after 34 days acupuncture therapy 6.058947862
GSM1694003 Peripheral blood mononuclear cells from HAP after 34 days acupuncture therapy, replicate 3 strain/background: Wistar gender: female cell type: peripheral blood mononuclear cells subject group: healthy rats after 34 days acupuncture therapy 23.61277271
GSM1694004 Peripheral blood mononuclear cells from AP after 34 days acupuncture therapy, replicate 1 strain/background: Wistar gender: female cell type: peripheral blood mononuclear cells subject group: rheumatoid arthritis rats after 34 days acupuncture therapy 34.593422811
GSM1694005 Peripheral blood mononuclear cells from AP after 34 days acupuncture therapy, replicate 2 strain/background: Wistar gender: female cell type: peripheral blood mononuclear cells subject group: rheumatoid arthritis rats after 34 days acupuncture therapy 20.6589362315
GSM1694006 Peripheral blood mononuclear cells from AP after 34 days acupuncture therapy, replicate 3 strain/background: Wistar gender: female cell type: peripheral blood mononuclear cells subject group: rheumatoid arthritis rats after 34 days acupuncture therapy 6.3931645244999995
GSM1694007 Peripheral blood mononuclear cells from MTXAP after 34 days MTX&acupuncture therapy, replicate 1 strain/background: Wistar gender: female cell type: peripheral blood mononuclear cells subject group: rheumatoid arthritis rats after 34 days methotrexate & acupuncture therapy 28.029576039000002
GSM1694008 Peripheral blood mononuclear cells from MTXAP after 34 days MTX&acupuncture therapy, replicate 2 strain/background: Wistar gender: female cell type: peripheral blood mononuclear cells subject group: rheumatoid arthritis rats after 34 days methotrexate & acupuncture therapy 12.343037323499999
GSM1694009 Peripheral blood mononuclear cells from MTXAP after 34 days MTX&acupuncture therapy, replicate 3 strain/background: Wistar gender: female cell type: peripheral blood mononuclear cells subject group: rheumatoid arthritis rats after 34 days methotrexate & acupuncture therapy 24.2991822775

ID GSE58460
Title Rheumatoid Arthritis Rat Model Treated with Acupuncture
Organism Rattus norvegicus
GSM Sample info Characteristics Value
GSM1165929 RAT_NORA_T0_1 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: healthy rats before therapy 3.626232605
GSM1165930 RAT_NORA_T0_2 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: healthy rats before therapy 3.4452183290000002
GSM1165931 RAT_RA_T0_1 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats before therapy 3.618621151
GSM1165932 RAT_RA_T0_2 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats before therapy 3.3902439375
GSM1165933 RAT_NORA_1h_1 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: healthy rats at 1 hour after therapy 3.4044192385
GSM1165934 RAT_NORA_1h_2 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: healthy rats at 1 hour after therapy 3.5186980525
GSM1165935 RAT_AP_1h_1 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 1 hour acupuncture therapy 3.6214350494999996
GSM1165936 RAT_AP_1h_2 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 1 hour acupuncture therapy 3.5573432929999997
GSM1165937 RAT_MTX_1h_1 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 1 hour MTX therapy 3.508356752
GSM1165938 RAT_MTX_1h_2 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 1 hour MTX therapy 3.449353157
GSM1165939 RAT_ANE_1h_1 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 1 hour ANE therapy 3.5669632785000003
GSM1165940 RAT_ANE_1h_2 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 1 hour ANE therapy 3.6663278205
GSM1165941 RAT_PLA_1h_1 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 1 hour placebo therapy 3.5410009794999997
GSM1165942 RAT_PLA_1h_2 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 1 hour placebo therapy 3.5825212889999998
GSM1165943 RAT_NORA_34d_1 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: healthy rats at 34 days after therapy 3.5633273465
GSM1165944 RAT_NORA_34d_2 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: healthy rats at 34 days after therapy 3.751248308
GSM1165945 RAT_AP_34d_1 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 34 days acupuncture therapy 3.964801006
GSM1165946 RAT_AP_34d_2 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 34 days acupuncture therapy 3.546411864
GSM1165947 RAT_MTX_34d_1 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 34 days MTX therapy 3.5459795105
GSM1165948 RAT_MTX_34d_2 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 34 days MTX therapy 3.7472863045
GSM1165949 RAT_ANE_34d_1 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 34 days ANE therapy 3.740013201
GSM1165950 RAT_ANE_34d_2 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 34 days ANE therapy 3.665898802
GSM1165951 RAT_PLA_34d_1 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 34 days placebo therapy 3.6172284325
GSM1165952 RAT_PLA_34d_2 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 34 days placebo therapy 3.529995739
GSM1412003 RAT_NORA_T0_1 strain: Wistar gender: Female tissue: RAT Peripheral blood mononuclear cells
GSM1412004 RAT_NORA_T0_2 strain: Wistar gender: Female tissue: RAT Peripheral blood mononuclear cells
GSM1412005 RAT_RA_T0_1 strain: Wistar gender: Female tissue: RAT Peripheral blood mononuclear cells
GSM1412006 RAT_RA_T0_2 strain: Wistar gender: Female tissue: RAT Peripheral blood mononuclear cells
GSM1412007 RAT_NORA_1h_1 strain: Wistar gender: Female tissue: RAT Peripheral blood mononuclear cells
GSM1412008 RAT_NORA_1h_2 strain: Wistar gender: Female tissue: RAT Peripheral blood mononuclear cells
GSM1412009 RAT_AP_1h_1 strain: Wistar gender: Female tissue: RAT Peripheral blood mononuclear cells
GSM1412010 RAT_AP_1h_2 strain: Wistar gender: Female tissue: RAT Peripheral blood mononuclear cells
GSM1412011 RAT_MTX_1h_1 strain: Wistar gender: Female tissue: RAT Peripheral blood mononuclear cells
GSM1412012 RAT_MTX_1h_2 strain: Wistar gender: Female tissue: RAT Peripheral blood mononuclear cells
GSM1412013 RAT_ANE_1h_1 strain: Wistar gender: Female tissue: RAT Peripheral blood mononuclear cells
GSM1412014 RAT_ANE_1h_2 strain: Wistar gender: Female tissue: RAT Peripheral blood mononuclear cells
GSM1412015 RAT_PLA_1h_1 strain: Wistar gender: Female tissue: RAT Peripheral blood mononuclear cells
GSM1412016 RAT_PLA_1h_2 strain: Wistar gender: Female tissue: RAT Peripheral blood mononuclear cells
GSM1412017 RAT_NORA_34d_1 strain: Wistar gender: Female tissue: RAT Peripheral blood mononuclear cells
GSM1412018 RAT_NORA_34d_2 strain: Wistar gender: Female tissue: RAT Peripheral blood mononuclear cells
GSM1412019 RAT_AP_34d_1 strain: Wistar gender: Female tissue: RAT Peripheral blood mononuclear cells
GSM1412020 RAT_AP_34d_2 strain: Wistar gender: Female tissue: RAT Peripheral blood mononuclear cells
GSM1412021 RAT_MTX_34d_1 strain: Wistar gender: Female tissue: RAT Peripheral blood mononuclear cells
GSM1412022 RAT_MTX_34d_2 strain: Wistar gender: Female tissue: RAT Peripheral blood mononuclear cells
GSM1412023 RAT_ANE_34d_1 strain: Wistar gender: Female tissue: RAT Peripheral blood mononuclear cells
GSM1412024 RAT_ANE_34d_2 strain: Wistar gender: Female tissue: RAT Peripheral blood mononuclear cells
GSM1412025 RAT_PLA_34d_1 strain: Wistar gender: Female tissue: RAT Peripheral blood mononuclear cells
GSM1412026 RAT_PLA_34d_2 strain: Wistar gender: Female tissue: RAT Peripheral blood mononuclear cells
GSM1412027 RAT_RA_T0_1 strain: Wistar gender: Female tissue: RAT Sub-epidermidis muscle tissue
GSM1412028 RAT_RA_T0_2 strain: Wistar gender: Female tissue: RAT Sub-epidermidis muscle tissue
GSM1412029 RAT_AP_1h_1 strain: Wistar gender: Female tissue: RAT Sub-epidermidis muscle tissue
GSM1412030 RAT_AP_1h_2 strain: Wistar gender: Female tissue: RAT Sub-epidermidis muscle tissue
GSM1412031 RAT_PLA_1h_1 strain: Wistar gender: Female tissue: RAT Sub-epidermidis muscle tissue
GSM1412032 RAT_PLA_1h_2 strain: Wistar gender: Female tissue: RAT Sub-epidermidis muscle tissue
GSM1412033 RAT_AP_34d_1 strain: Wistar gender: Female tissue: RAT Sub-epidermidis muscle tissue
GSM1412034 RAT_AP_34d_2 strain: Wistar gender: Female tissue: RAT Sub-epidermidis muscle tissue
GSM1412035 RAT_PLA_34d_1 strain: Wistar gender: Female tissue: RAT Sub-epidermidis muscle tissue
GSM1412036 RAT_PLA_34d_2 strain: Wistar gender: Female tissue: RAT Sub-epidermidis muscle tissue
GSM1693996 Peripheral blood mononuclear cells from NORA before therapy, replicate 1 strain/background: Wistar gender: female cell type: peripheral blood mononuclear cells subject group: healthy rats before therap 4.5598524005
GSM1693997 Peripheral blood mononuclear cells from NORA before therapy, replicate 2 strain/background: Wistar gender: female cell type: peripheral blood mononuclear cells subject group: healthy rats before therapy 20.264343716
GSM1693998 Peripheral blood mononuclear cells from NORA before therapy, replicate 3 strain/background: Wistar gender: female cell type: peripheral blood mononuclear cells subject group: healthy rats before therapy 47.7512115775
GSM1693999 Peripheral blood mononuclear cells from RA before therapy, replicate 1 strain/background: Wistar gender: female cell type: peripheral blood mononuclear cells subject group: rheumatoid arthritis rats before therapy 26.159692470000003
GSM1694000 Peripheral blood mononuclear cells from RA before therapy, replicate 2 strain/background: Wistar gender: female cell type: peripheral blood mononuclear cells subject group: rheumatoid arthritis rats before therapy 10.142869801
GSM1694001 Peripheral blood mononuclear cells from HAP after 34 days acupuncture therapy, replicate 1 strain/background: Wistar gender: female cell type: peripheral blood mononuclear cells subject group: healthy rats after 34 days acupuncture therapy 35.9991532505
GSM1694002 Peripheral blood mononuclear cells from HAP after 34 days acupuncture therapy, replicate 2 strain/background: Wistar gender: female cell type: peripheral blood mononuclear cells subject group: healthy rats after 34 days acupuncture therap 6.058947862
GSM1694003 Peripheral blood mononuclear cells from HAP after 34 days acupuncture therapy, replicate 3 strain/background: Wistar gender: female cell type: peripheral blood mononuclear cells subject group: healthy rats after 34 days acupuncture therapy 23.61277271
GSM1694004 Peripheral blood mononuclear cells from AP after 34 days acupuncture therapy, replicate 1 strain/background: Wistar gender: female cell type: peripheral blood mononuclear cells subject group: rheumatoid arthritis rats after 34 days acupuncture therapy 34.593422811
GSM1694005 Peripheral blood mononuclear cells from AP after 34 days acupuncture therapy, replicate 2 strain/background: Wistar gender: female cell type: peripheral blood mononuclear cells subject group: rheumatoid arthritis rats after 34 days acupuncture therapy 20.6589362315
GSM1694006 Peripheral blood mononuclear cells from AP after 34 days acupuncture therapy, replicate 3 strain/background: Wistar gender: female cell type: peripheral blood mononuclear cells subject group: rheumatoid arthritis rats after 34 days acupuncture therapy 6.3931645244999995
GSM1694007 Peripheral blood mononuclear cells from MTXAP after 34 days MTX&acupuncture therapy, replicate 1 strain/background: Wistar gender: female cell type: peripheral blood mononuclear cells subject group: rheumatoid arthritis rats after 34 days methotrexate & acupuncture therapy 28.029576039000002
GSM1694008 Peripheral blood mononuclear cells from MTXAP after 34 days MTX&acupuncture therapy, replicate 2 strain/background: Wistar gender: female cell type: peripheral blood mononuclear cells subject group: rheumatoid arthritis rats after 34 days methotrexate & acupuncture therapy 12.343037323499999
GSM1694009 Peripheral blood mononuclear cells from MTXAP after 34 days MTX&acupuncture therapy, replicate 3 strain/background: Wistar gender: female cell type: peripheral blood mononuclear cells subject group: rheumatoid arthritis rats after 34 days methotrexate & acupuncture therapy 24.2991822775

ID GSE752
Title Halothane/Isoflurane Repetitive Exposures
Organism Rattus norvegicus
GSM Sample info Characteristics Value
GSM5082 Control 1 48.166666666666664
GSM5084 Control 2 51.166666666666664
GSM5085 Control 3 51.599999999999994
GSM5086 Control 4 67.73333333333333
GSM5087 Control 5 57.86666666666667
GSM5090 Control 6 54.36666666666667
GSM5105 Control 7 64.06666666666668
GSM5106 Control 8 59.666666666666664
GSM5107 Control 9 69.10000000000001
GSM5108 Halothane 10 exposure-1 48.56666666666666
GSM5109 Halothane 10 exposures-2 50.73333333333333
GSM5110 Halothane 10 exposures-3 50.699999999999996
GSM5111 Halothane 5 exposures-1 49.13333333333333
GSM5112 Halothane 5 exposures-2 50.133333333333326
GSM5113 Halothane 5 exposures-3 43.43333333333334
GSM5114 Isoflurane 10 exposures-1 35.1
GSM5115 Isoflurane 10 exposures-2 77.56666666666668
GSM5116 Isoflurane 10 exposures-3 40.199999999999996
GSM5117 Isoflurane 5 exposures-1 50.300000000000004
GSM5118 Isoflurane 5 exposures-2 59.800000000000004
GSM5119 Isoflurane 5 exposures-3 52.56666666666666
GSM11379 Control 10 50.166666666666664
GSM11380 Control 11 46.800000000000004
GSM11381 Control 12 45.93333333333334

ID GSE8911
Title Skeletal muscle after fine needle stimulation
Organism Rattus norvegicus
GSM Sample info Characteristics Value
GSM225891 Skeletal muscle sample from fine needle-stimulated hindlimb Strain: Lewis, Gender: Male, Body Weight: 275g, Tissue: Skeletal muscle sample from fine nnedle-stimulated hindlimb 7.67874
GSM225892 Skeletal muscle sample from control hindlimb Strain: Lewis, Gender: Male, Body weight: 275g, Tissue: skeletal muscle sample from non fine needle-stimulated hindlimb 24.749399999999998